CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 22 filers reported holding CLEVELAND BIOLABS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $33,000 | -25.0% | 16,651 | -2.1% | 0.00% | -33.3% |
| Q2 2020 | $44,000 | +51.7% | 17,013 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $29,000 | +190.0% | 17,013 | +7.2% | 0.00% | +100.0% |
| Q4 2019 | $10,000 | -37.5% | 15,863 | +1.8% | 0.00% | -50.0% |
| Q3 2019 | $16,000 | – | 15,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 281,916 | $567,000 | 0.00% |
| VANGUARD GROUP INC | 170,347 | $342,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 20 | $0 | 0.00% |
| UBS Group AG | 2,056 | $4,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 100 | $0 | 0.00% |
| IFP Advisors, Inc | 150 | $0 | 0.00% |
| Advisor Group, Inc. | 25 | $0 | 0.00% |
| US BANCORP \DE\ | 100 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 253 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |